The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and Machine Learning (ML) in drug development. Moderated by Henry Wei, MD, Head of Development Innovation at Regeneron, the panel included Charles Fisher, PhD, CEO and Founder of Unlearn.AI; Sid Jain, VP of Global Development Data Science & Digital Health at Janssen Research & Development; Nareen Katta, MBA, Head of Data Science & Analytics, Global Therapeutics – Clinical Development at AbbVie; Prasanna Rao, Senior Director, Global Head of AI/ML, Clinical Data Sciences, GPD at Pfizer; and Marsha E. Samson, PhD, MPH, MSHSA, Senior Analyst at the FDA, CDER/Office of Medical Policy.